22 related articles for article (PubMed ID: 38474265)
1. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
2. Identification of CD114 Membrane Receptors as a Molecular Target in Medulloblastomas.
Monteiro JM; Reis Ramos JI; Teixeira E Sousa I; Bighetti-Trevisan RL; Ribas Filho JM; Isolan GR
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982406
[TBL] [Abstract][Full Text] [Related]
3. Characterization of G-CSF receptor expression in medulloblastoma.
Paul MR; Huo Y; Liu A; Lesperance J; Garancher A; Wechsler-Reya RJ; Zage PE
Neurooncol Adv; 2020; 2(1):vdaa062. PubMed ID: 32642714
[TBL] [Abstract][Full Text] [Related]
4. Integrated transcriptome, proteome and single-cell sequencing uncover the prognostic and immunological features of colony-stimulating factor 3 receptor in pan-cancer.
Song L; Jiang F; Tian Y; Cao X; Zhu M; Zhang J; Wang X; Deng L
J Gene Med; 2023 Oct; 25(10):e3508. PubMed ID: 36998239
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system.
Adamson DC; Rasheed BA; McLendon RE; Bigner DD
Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
[TBL] [Abstract][Full Text] [Related]
6. Molecular biology of malignant gliomas.
Belda-Iniesta C; de Castro Carpeño J; Casado Sáenz E; Cejas Guerrero P; Perona R; González Barón M
Clin Transl Oncol; 2006 Sep; 8(9):635-41. PubMed ID: 17005465
[TBL] [Abstract][Full Text] [Related]
7. [Tumor progression of diffuse median glioma with H3 K27 alteration from pilocytic astrocytoma to glioblastoma].
Zabrodskaya YM; Sidorin VS; Nikolaenko MS; Samochernikh KA
Arkh Patol; 2022; 84(6):40-46. PubMed ID: 36469716
[TBL] [Abstract][Full Text] [Related]
8. Gene Expression of
Bark SA; Dalmolin M; Malafaia O; Roesler R; Fernandes MAC; Isolan GR
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474265
[TBL] [Abstract][Full Text] [Related]
9. CD114: A New Member of the Neural Crest-Derived Cancer Stem Cell Marker Family.
Zage PE; Whittle SB; Shohet JM
J Cell Biochem; 2017 Feb; 118(2):221-231. PubMed ID: 27428599
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
